A substantial number of AI images generated or edited with Grok are targeting women in religious and cultural clothing.

Every time you shop online, fill out a form, or check out at your favorite website, invisible code might be watching.

gorilla/csrf is a HTTP middleware library that provides cross-site request forgery (CSRF) protection. It includes: ...and then collect the token with csrf.Token(r) in your handlers before passing it ...

For everything that’s gone right for the Seattle Seahawks during a season in which they’ve become one of the NFL’s top teams, ...

Researchers uncovered 27 malicious npm packages used over five months to host phishing pages that steal credentials from ...

Abstract: JavaScript plays an important role in web applications and services, which is used by millions of web pages in optimizing interface design, embedding dynamic texts, reading and writing HTML ...

The Special Intensive Revision (SIR) process is a major activity of the Election Commission of India to keep electoral rolls accurate, up to date, and free of errors, in advance of major elections. As ...

The process for the Special Intensive Revision (SIR) of electoral rolls have already started in West Bengal and people are submitting their SIR forms or Enumeration Form. If you have submitted the ...

SIR in Bengal: All voters, who are away from West Bengal, can now fill up the enumeration forms online. The online forms for Special Intensive Revision (SIR) have been made live following a brief ...

Starting October 1, 2025, foreign nationals and OCI cardholders must submit a mandatory e-arrival card before immigration in India. This digital initiative by the Bureau of Immigration aims to ...

We list the best online form builders, to make it simple and easy to collect, organize and analyze website data such as customer feedback and marketing analytics. All of the best online form builders ...

In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...